Extracorporeal membrane oxygenation as a bridge to lung transplantation following paraquat poisoning.

IF 0.6 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Sowmya Kantimathinathan, Paul Ramesh Thangaraj, Thirugnanasambandan Sunder, Madhan Kumar Kuppuswamy, Selvi Chinnasamy, Kalimuthu Balasubramanian Sriraman, Emmanuel Manohar Rajasingh
{"title":"Extracorporeal membrane oxygenation as a bridge to lung transplantation following paraquat poisoning.","authors":"Sowmya Kantimathinathan, Paul Ramesh Thangaraj, Thirugnanasambandan Sunder, Madhan Kumar Kuppuswamy, Selvi Chinnasamy, Kalimuthu Balasubramanian Sriraman, Emmanuel Manohar Rajasingh","doi":"10.1007/s12055-024-01893-5","DOIUrl":null,"url":null,"abstract":"<p><p>Paraquat poisoning contributes to nearly 14.4% of the total poisoning cases in southern India. When ingested, it leads to renal and liver damage. It accumulates in alveolar cells and through reactive oxygen species damage, it can lead to pulmonary fibrosis. Once pulmonary fibrosis is established, the ensuing respiratory failure is irreversible. The previously reported duration of extracorporeal membrane oxygenation (ECMO) to support the respiratory function in paraquat poisoning, as a bridge to lung transplantation, ranged between 1 and 2 days. We demonstrate the use of long-term awake veno-venous (VV) ECMO in two patients (70 and 67 days), after paraquat poisoning as a bridge to lung transplantation. We describe the advantages of awake ECMO in patients requiring extended ECMO support mainly in the form of nutritional, physical, and psychiatric rehabilitation. This is of importance in these patients, and awake ECMO provides an excellent method to achieve an optimum physical status prior to lung transplantation.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"41 8","pages":"1027-1032"},"PeriodicalIF":0.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276182/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12055-024-01893-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/8 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Paraquat poisoning contributes to nearly 14.4% of the total poisoning cases in southern India. When ingested, it leads to renal and liver damage. It accumulates in alveolar cells and through reactive oxygen species damage, it can lead to pulmonary fibrosis. Once pulmonary fibrosis is established, the ensuing respiratory failure is irreversible. The previously reported duration of extracorporeal membrane oxygenation (ECMO) to support the respiratory function in paraquat poisoning, as a bridge to lung transplantation, ranged between 1 and 2 days. We demonstrate the use of long-term awake veno-venous (VV) ECMO in two patients (70 and 67 days), after paraquat poisoning as a bridge to lung transplantation. We describe the advantages of awake ECMO in patients requiring extended ECMO support mainly in the form of nutritional, physical, and psychiatric rehabilitation. This is of importance in these patients, and awake ECMO provides an excellent method to achieve an optimum physical status prior to lung transplantation.

体外膜氧合作为百草枯中毒后肺移植的桥梁。
在印度南部,百草枯中毒占中毒总病例的近14.4%。当摄入时,它会导致肾脏和肝脏损伤。它在肺泡细胞中积累,通过活性氧损伤,可导致肺纤维化。一旦肺纤维化建立,随后的呼吸衰竭是不可逆转的。先前报道的支持百草枯中毒患者呼吸功能的体外膜氧合(ECMO),作为肺移植的桥梁,持续时间在1至2天之间。我们展示了在两个患者(70天和67天)中使用长期清醒的静脉-静脉(VV) ECMO,在百草草中毒后作为肺移植的桥梁。我们描述了清醒ECMO在需要扩展ECMO支持的患者中的优势,主要是在营养、身体和精神康复方面。这对这些患者很重要,清醒ECMO为肺移植前达到最佳身体状态提供了一种极好的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Thoracic and Cardiovascular Surgery
Indian Journal of Thoracic and Cardiovascular Surgery CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.20
自引率
14.30%
发文量
141
期刊介绍: The primary aim of the Indian Journal of Thoracic and Cardiovascular Surgery is education. The journal aims to dissipate current clinical practices and developments in the area of cardiovascular and thoracic surgery. This includes information on cardiovascular epidemiology, aetiopathogenesis, clinical manifestation etc. The journal accepts manuscripts from cardiovascular anaesthesia, cardiothoracic and vascular nursing and technology development and new/innovative products.The journal is the official publication of the Indian Association of Cardiovascular and Thoracic Surgeons which has a membership of over 1000 at present.DescriptionThe journal is the official organ of the Indian Association of Cardiovascular-Thoracic Surgeons. It was started in 1982 by Dr. Solomon Victor and ws being published twice a year up to 1996. From 2000 the editorial office moved to Delhi. From 2001 the journal was extended to quarterly and subsequently four issues annually have been printed out at time and regularly without fail. The journal receives manuscripts from members and non-members and cardiovascular surgeons. The manuscripts are peer reviewed by at least two or sometimes three or four reviewers who are on the panel. The manuscript process is now completely online. Funding the journal comes partially from the organization and from revenue generated by subscription and advertisement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信